Literature DB >> 17943966

Immunizations for children with cancer.

Upton D Allen1.   

Abstract

Children with malignant diseases are at risk of severe outcomes from vaccine preventable infections. Vaccination of these children presents challenges due to efficacy and safety concerns. There is a paucity of data on several aspects of vaccination in this group of children. Consequently, for the most part, data are extrapolated from healthy populations and combined with experts' opinions. This article reviews the use of vaccines in infants and children with cancer. In this context, an all-encompassing review is not the goal. Key principles are reviewed to provide a framework to guide the use of vaccines in children with malignant diseases. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17943966     DOI: 10.1002/pbc.21346

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation.

Authors:  Avinash K Shetty; Mary A Winter
Journal:  Ochsner J       Date:  2012

Review 2.  Guidelines on vaccinations in paediatric haematology and oncology patients.

Authors:  Simone Cesaro; Mareva Giacchino; Francesca Fioredda; Angelica Barone; Laura Battisti; Stefania Bezzio; Stefano Frenos; Raffaella De Santis; Susanna Livadiotti; Serena Marinello; Andrea Giulio Zanazzo; Désirée Caselli
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

3.  Assessment of antibody titers and immunity to Hepatitis B in children receiving chemotherapy.

Authors:  A Shams Shahemabadi; F Salehi; A Hashemi; M Vakili; F Zare; N Esphandyari; S Kashanian
Journal:  Iran J Ped Hematol Oncol       Date:  2012-09-22

4.  "My son can not attend the school because 5 classmates are unvaccinated". On the question of compulsory vaccinations and the risk for immune-compromised children into the schools: the case of paediatric cancer patients.

Authors:  Silvana Acquafredda; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2018-11-05       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.